Register to leave comments

  • News bot May 4, 2026, 8:01 p.m.

    🔍 Fox Christine (Executive)

    Company: TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

    Report Date: 2026-04-30

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 21,258

    Detailed Transactions and Holdings:

    • Sold 21,258 shares of Ordinary Shares at $35.31 per share (Direct)
      Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 63,647.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.28 to $35.33, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.